Literature DB >> 11859079

Two defective heterozygous luteinizing hormone receptors can rescue hormone action.

ChangWoo Lee1, Inhae Ji, KiSung Ryu, YongSang Song, P Michael Conn, Tae H Ji.   

Abstract

Luteinizing hormone receptor is a G protein-coupled receptor and consists of two halves: the N-terminal extracellular half (exodomain) and C-terminal membrane-associated half (endodomain). Hormone binds to the exodomain, and the resulting hormone-exodomain complex modulates the endodomain to generate signals. There are mutations that impair either hormone binding or signal generation. We report that the coexpression of a binding defective mutant and a signal-defective mutant rescues signal generation to produce cAMP. This rescue requires both types of mutant receptors and is dependent on the human chorionic gonadotropin dose, the surface concentration of mutant receptors, and the amino acid position of mutations. Furthermore, random collisions among mutant receptors are not involved in the rescue. Our observations provide new insights into the mechanisms of the functional and structural relationship of the exo- and endodomain, signal transduction, and receptor genetics, in particular for defective heterozygotes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11859079     DOI: 10.1074/jbc.M111818200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Revisiting and questioning functional rescue between dimerized LH receptor mutants.

Authors:  Meilin Zhang; Rongbin Guan; Deborah L Segaloff
Journal:  Mol Endocrinol       Date:  2012-03-08

2.  Trans-activation, cis-activation and signal selection of gonadotropin receptors.

Authors:  MyoungKun Jeoung; ChangWoo Lee; Inhae Ji; Tae H Ji
Journal:  Mol Cell Endocrinol       Date:  2006-10-19       Impact factor: 4.102

3.  Constitutive dimerization of the G-protein coupled receptor, neurotensin receptor 1, reconstituted into phospholipid bilayers.

Authors:  Peter J Harding; Helen Attrill; Jonas Boehringer; Simon Ross; George H Wadhams; Eleanor Smith; Judith P Armitage; Anthony Watts
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

4.  Bioluminescence resonance energy transfer studies reveal constitutive dimerization of the human lutropin receptor and a lack of correlation between receptor activation and the propensity for dimerization.

Authors:  Rongbin Guan; Xiuyan Feng; Xueqing Wu; Meilin Zhang; Xuesen Zhang; Terence E Hébert; Deborah L Segaloff
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

5.  Distinct mechanisms of cAMP induction by constitutively activating LH receptor and wild-type LH receptor activated by hCG.

Authors:  ChangWoo Lee; Inhae Ji; Tae H Ji
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

Review 6.  The year in G protein-coupled receptor research.

Authors:  Robert P Millar; Claire L Newton
Journal:  Mol Endocrinol       Date:  2009-12-17

Review 7.  G protein-coupled receptors: walking hand-in-hand, talking hand-in-hand?

Authors:  Henry F Vischer; Anne O Watts; Saskia Nijmeijer; Rob Leurs
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

8.  An in vivo demonstration of functional G protein-coupled receptor dimers.

Authors:  Gilbert Vassart
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

9.  Single-molecule analyses of fully functional fluorescent protein-tagged follitropin receptor reveal homodimerization and specific heterodimerization with lutropin receptor.

Authors:  Joseph E Mazurkiewicz; Katharine Herrick-Davis; Margarida Barroso; Alfredo Ulloa-Aguirre; Barbara Lindau-Shepard; Richard M Thomas; James A Dias
Journal:  Biol Reprod       Date:  2015-03-11       Impact factor: 4.285

10.  Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation.

Authors:  Adolfo Rivero-Müller; Yen-Yin Chou; Inhae Ji; Svetlana Lajic; Aylin C Hanyaloglu; Kim Jonas; Nafis Rahman; Tae H Ji; Ilpo Huhtaniemi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.